Mounjaro - Eli Lilly®

Mounjaro - Eli Lilly®

4-week cycle

Important Safety Information for Mounjaro®

Do not share your Mounjaro® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

What is the most important information I should know about Mounjaro®?

Mounjaro® may cause serious side effects, including:

• Possible thyroid tumors, including cancer. Tell your health care provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, medicines like Mounjaro® caused thyroid tumors, including a type of thyroid cancer called medullary thyroid carcinoma (MTC). It is not known if Mounjaro® will cause thyroid tumors or MTC in people.
• Do not use Mounjaro® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What is Mounjaro®?

Mounjaro® (tirzepatide) injection, available in multiple dose strengths (2.5 mg to 15 mg), is a once-weekly injectable prescription medicine used:

• along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
• to help with weight loss and long-term weight management in adults with obesity (BMI ≥30), or overweight (BMI ≥27) with at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes.

Mounjaro® is not for use in people with type 1 diabetes.

It is not known if Mounjaro® can be used in people who have had pancreatitis.

It is also not known if Mounjaro® is safe and effective for use in children under 18 years of age.

Important Safety Information

Do not use Mounjaro® if:

• you or any of your family have ever had MTC or if you have MEN 2.
• you are allergic to tirzepatide or any of the ingredients in Mounjaro®. See symptoms of a serious allergic reaction in “What are the possible side effects of Mounjaro®?”

Before using Mounjaro®, tell your health care provider if you:

• have or have had problems with your pancreas or kidneys.
• have a history of diabetic retinopathy.
• are pregnant, plan to become pregnant, or are breastfeeding. It is not known if Mounjaro® will harm your unborn baby or if it passes into your breast milk. You should stop using Mounjaro® at least 1 month before you plan to become pregnant.

Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.

What are the possible side effects of Mounjaro®?

Mounjaro® may cause serious side effects, including:

• Inflammation of your pancreas (pancreatitis). Stop using Mounjaro® and call your healthcare provider right away if you have severe stomach pain that doesn’t go away, with or without vomiting.
• Low blood sugar (hypoglycemia). Your risk of low blood sugar may be higher if you use Mounjaro® with another diabetes medicine such as insulin or a sulfonylurea. Symptoms may include dizziness, blurred vision, anxiety, mood changes, sweating, shakiness, confusion, or fast heartbeat.
• Kidney problems (kidney failure). Nausea, vomiting, and diarrhea from Mounjaro® may lead to dehydration, which can worsen kidney problems.
• Severe allergic reactions. Stop using Mounjaro® and seek medical help immediately if you experience swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; a severe rash; or a rapid heartbeat.
• Gallbladder problems. Tell your healthcare provider right away if you experience upper abdominal pain, fever, yellowing of the skin or eyes (jaundice), or pale stools.
• Changes in vision. Contact your healthcare provider if you notice any vision changes while taking Mounjaro®.

The most common side effects of Mounjaro® include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain.